相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
Xiao-Su Zhao et al.
ANNALS OF HEMATOLOGY (2012)
Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis
Y. Wang et al.
BONE MARROW TRANSPLANTATION (2012)
Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
X-S Zhao et al.
BONE MARROW TRANSPLANTATION (2012)
The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation
Ming-Rui Huo et al.
CLINICAL TRANSPLANTATION (2012)
Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Regression modeling of competing risk using R: an in depth guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2010)
Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status
Ying-Jun Chang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation
Xiao-Jun Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic Malignancies
Huang Xiao-Jun et al.
CLINICAL CANCER RESEARCH (2009)
HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase
Huang Xiao-Jun et al.
ANNALS OF MEDICINE (2008)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children
Daihong Liu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States
F. Aversa
BONE MARROW TRANSPLANTATION (2008)
Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases
R. A. Brodsky et al.
BONE MARROW TRANSPLANTATION (2008)
Unmanipulated or CD34 selected haplotype mismatched transplants
Yubin Kang et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis
Hiroyasu Ogawa et al.
EXPERIMENTAL HEMATOLOGY (2008)
Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia
Xiao-Jun Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Current status of haploidentical stem cell transplantation for leukemia
Xiao-jun Huang
JOURNAL OF HEMATOLOGY & ONCOLOGY (2008)
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation
Xiao-Jun Huang et al.
HAEMATOLOGICA (2007)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4(+)CD25(+) T-cell-dependent mechanism
K Matsuoka et al.
BLOOD (2006)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Feasibility of HLA-haploidentical hematopoletic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomatemal microchimerism
T Ichinohe et al.
BLOOD (2004)
Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance
K Obama et al.
BONE MARROW TRANSPLANTATION (2004)
The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: A single-center experience in Korea
HJ Kim et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling
JJ van Rood et al.
BLOOD (2002)
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience
J Sierra et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
